Back

Obesity Medicine Association

  • Anti-Obesity Agents
  • Obesity
  • Therapies, Investigational

Obesity Medicine 2025 – Investigational Anti-Obesity Drugs in the Pipeline (Recorded)

This presentation explores emerging investigational therapies designed to combat obesity. Attendees will gain insights into the mechanisms of action driving these innovative drugs, as well as a critical evaluation of the latest clinical trial data, including efficacy, safety, and clinical outcomes. Additionally, the session will address how these future therapies could complement existing anti-obesity medications, paving the way for more effective and integrated treatment strategies. CME/CE Expiration Date: 4/27/28 *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

ABS — Accredited CMEUp to 1 point

FDA REMS

No

Qualifies for MIPS

No

Faculty 1

All faculty

Pricing

$25

Standard

Listed by the provider · academy.obesitymedicine.org

  • On-demand / recorded video
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • $25
  • Released
    Apr 29, 2025
  • Last day to claim credit
    Apr 28, 2028 2 years left